External validation of the Heidenreich criteria for patient selection for unilateral or bilateral retroperitoneal lymph node dissection for post-chemotherapy residual masses of testicular cancer.
Vallier, Cédric
External validation of the Heidenreich criteria for patient selection for unilateral or bilateral retroperitoneal lymph node dissection for post-chemotherapy residual masses of testicular cancer. [electronic resource] - World journal of urology Dec 2014 - 1573-8 p. digital
Publication Type: Journal Article
1433-8726
10.1007/s00345-014-1240-6 doi
Adult
Antineoplastic Agents--therapeutic use
Cohort Studies
Combined Modality Therapy
Disease-Free Survival
Humans
Lymph Node Excision
Male
Neoplasm Recurrence, Local--diagnosis
Neoplasm, Residual
Neoplasms, Germ Cell and Embryonal--diagnosis
Patient Selection
Reproducibility of Results
Retroperitoneal Space
Testicular Neoplasms--diagnosis
External validation of the Heidenreich criteria for patient selection for unilateral or bilateral retroperitoneal lymph node dissection for post-chemotherapy residual masses of testicular cancer. [electronic resource] - World journal of urology Dec 2014 - 1573-8 p. digital
Publication Type: Journal Article
1433-8726
10.1007/s00345-014-1240-6 doi
Adult
Antineoplastic Agents--therapeutic use
Cohort Studies
Combined Modality Therapy
Disease-Free Survival
Humans
Lymph Node Excision
Male
Neoplasm Recurrence, Local--diagnosis
Neoplasm, Residual
Neoplasms, Germ Cell and Embryonal--diagnosis
Patient Selection
Reproducibility of Results
Retroperitoneal Space
Testicular Neoplasms--diagnosis